Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Angle Plc (AGL.LN)

Angle Plc (AGL.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Angle Plc 10 Nugent Road The Surrey Research Park Guildford GU2 7AF GBR

https://www.angleplc.com P: 148-334-3434

Description:

ANGLE PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.

Key Statistics

Overview:

Market Capitalization, $K 35,478
Shares Outstanding, K 322,528
Annual Sales, $ 2,186 K
Annual Net Income, $ -20,132 K
% of Insider Shareholders 2.69%
% of Institutional Shareholders 17.48%

Growth:

1-Year Return -41.02%
3-Year Return -92.04%
5-Year Return -86.22%
5-Year Revenue Growth 24.59%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.08
Dividend Payout Ratio 0.00%

AGL.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -63.91%
Return-on-Assets % -49.68%
Profit Margin % -920.95%
Debt/Equity 0.17
Price/Sales 13.13
Price/Book 1.55
Book Value/Share 0.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar